Literature DB >> 18534980

Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase.

Lobelia Samavati1, Icksoo Lee, Isabella Mathes, Friedrich Lottspeich, Maik Hüttemann.   

Abstract

Mitochondrial oxidative phosphorylation provides most cellular energy. As part of this process, cytochrome c oxidase (CcO) pumps protons across the inner mitochondrial membrane, contributing to the generation of the mitochondrial membrane potential, which is used by ATP synthase to produce ATP. During acute inflammation, as in sepsis, aerobic metabolism appears to malfunction and switches to glycolytic energy production. The pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha) has been shown to play a central role in inflammation. We hypothesized that TNFalpha-triggered cell signaling targets CcO, which is a central enzyme of the aerobic energy metabolism and can be regulated through phosphorylation. Using total bovine and murine hepatocyte homogenates TNFalpha treatment led to an approximately 60% reduction in CcO activity. In contrast, there was no direct effect of TNFalpha on CcO activity using isolated mitochondria and purified CcO, indicating that a TNFalpha-triggered intracellular signaling cascade mediates CcO inhibition. CcO isolated after TNFalpha treatment showed tyrosine phosphorylation on CcO catalytic subunit I and was approximately 50 and 70% inhibited at high cytochrome c concentrations in the presence of allosteric activator ADP and inhibitor ATP, respectively. CcO phosphorylation occurs on tyrosine 304 as demonstrated with a phosphoepitope-specific antibody. Furthermore, the mitochondrial membrane potential was decreased in H2.35 cells in response to TNFalpha. Concomitantly, cellular ATP was more than 35 and 64% reduced in murine hepatocytes and H2.35 cells. We postulate that an important contributor in TNFalpha-mediated pathologies, such as sepsis, is energy paucity, which parallels the poor tissue oxygen extraction and utilization found in such patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534980      PMCID: PMC3258931          DOI: 10.1074/jbc.M801954200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Reactive oxygen species are downstream products of TRAF-mediated signal transduction.

Authors:  N S Chandel; P T Schumacker; R H Arch
Journal:  J Biol Chem       Date:  2001-09-14       Impact factor: 5.157

2.  Effect of cytochrome c on the generation and elimination of O2*- and H2O2 in mitochondria.

Authors:  Yungang Zhao; Zhi-Bo Wang; Jian-Xing Xu
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

Review 3.  Molecular mechanisms controlling the localisation of protein kinase A.

Authors:  Gerard Griffioen; Johan M Thevelein
Journal:  Curr Genet       Date:  2002-06-27       Impact factor: 3.886

4.  Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types.

Authors:  G Villani; M Greco; S Papa; G Attardi
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

5.  Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized.

Authors:  E C Ledgerwood; J B Prins; N A Bright; D R Johnson; K Wolfreys; J S Pober; S O'Rahilly; J R Bradley
Journal:  Lab Invest       Date:  1998-12       Impact factor: 5.662

6.  Cytochrome c oxidase of mammals contains a testes-specific isoform of subunit VIb--the counterpart to testes-specific cytochrome c?

Authors:  Maik Hüttemann; Saied Jaradat; Lawrence I Grossman
Journal:  Mol Reprod Dev       Date:  2003-09       Impact factor: 2.609

7.  The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A.

Authors:  T Tsukihara; H Aoyama; E Yamashita; T Tomizaki; H Yamaguchi; K Shinzawa-Itoh; R Nakashima; R Yaono; S Yoshikawa
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

8.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

9.  A third isoform of cytochrome c oxidase subunit VIII is present in mammals.

Authors:  Maik Hüttemann; Timothy R Schmidt; Lawrence I Grossman
Journal:  Gene       Date:  2003-07-17       Impact factor: 3.688

10.  Regulation of cytochrome c oxidase activity by c-Src in osteoclasts.

Authors:  Tsuyoshi Miyazaki; Lynn Neff; Sakae Tanaka; William C Horne; Roland Baron
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

View more
  83 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

Review 2.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

3.  Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria.

Authors:  Etienne Hébert Chatelain; Jean-William Dupuy; Thierry Letellier; Jeanne Dachary-Prigent
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

Review 4.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Lawrence I Grossman; Jeffrey W Doan; Thomas H Sanderson
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin.

Authors:  Ravindar R Thomas; Shaharyar M Khan; Francisco R Portell; Rafal M Smigrodzki; James P Bennett
Journal:  Mitochondrion       Date:  2010-08-18       Impact factor: 4.160

Review 6.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 7.  Mitochondrial bioenergetics and pulmonary dysfunction: Current progress and future directions.

Authors:  Vadim S Ten; Veniamin Ratner
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

8.  TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.

Authors:  Christian P Bauerfeld; Ruchi Rastogi; Gaila Pirockinaite; Icksoo Lee; Maik Hüttemann; Bobby Monks; Morris J Birnbaum; Luigi Franchi; Gabriel Nuñez; Lobelia Samavati
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

9.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

10.  Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle.

Authors:  K Højlund; Z Yi; N Lefort; P Langlais; B Bowen; K Levin; H Beck-Nielsen; L J Mandarino
Journal:  Diabetologia       Date:  2009-12-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.